← Insider buys

Jason N Gorevic has bought stock on 3 days since Aug 2022

Director at Kemper Corporation, and 1 other company

SEC CIK 0001208500 · Filings on SEC.gov ↗

$357KBought
$133.1MSold
Aug 11Last buy

Jason N Gorevic's record

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Companies

Every filing

57 filings since Jul 2016, newest first

KMPRBuy

KEMPER Corp

Director

$130K+18.7%Aug 11
KMPRBuy

Kemper Corp

Director

$98K+10.0%Aug 7
TDOCSell

Teladoc Health, Inc.

CEO

$780K−8.0%Mar 5
TDOCSell

Teladoc Health, Inc.

CEO

$54KDec 5
TDOCSell

Teladoc Health, Inc.

CEO

$66KSep 6
TDOCSell

Teladoc Health, Inc.

CEO

$300K−2.0%Jul 28
TDOCSell

Teladoc Health, Inc.

CEO

$68KJun 5
TDOCSell

Teladoc Health, Inc.

CEO

$571K−4.0%Mar 7
TDOCSell

Teladoc Health, Inc.

CEO

$210K−1.0%Mar 3
KMPRBuy

Kemper Corp

Director

$129K+33.0%Aug 3
TDOCSell

Teladoc Health, Inc.

CEO

$1.5M−2.0%Nov 4
TDOCSell

Teladoc Health, Inc.

CEO

$1.5M−2.0%Aug 5
TDOCSell

Teladoc Health, Inc.

CEO

$1.6M−2.0%Jul 7
TDOCSell

Teladoc Health, Inc.

CEO

$1.5M−2.0%Jun 2
TDOCSell

Teladoc Health, Inc.

CEO

$4.2M−4.0%May 10
TDOCSell

Teladoc Health, Inc.

CEO

$1.6M−2.0%May 6
TDOCSell

Teladoc Health, Inc.

CEO

$4.6M−4.0%Apr 8
TDOCSell

Teladoc Health, Inc.

CEO

$3.7M−3.0%Mar 9
TDOCSell

Teladoc Health, Inc.

CEO

$3.9M−3.0%Mar 5
TDOCSell

Teladoc Health, Inc.

CEO

$9.5M−7.0%Mar 3
TDOCSell

Teladoc Health, Inc.

CEO

$8.1M−5.0%Feb 4
TDOCSell

Teladoc Health, Inc.

CEO

$6.0M−5.0%Jan 6
TDOCSell

Teladoc Health, Inc.

CEO

$1.0M−1.0%Dec 7
TDOCSell

Teladoc Health, Inc.

CEO

$4.9M−4.0%Dec 3
TDOCSell

Teladoc Health, Inc.

CEO

$5.8M−4.0%Nov 6
TDOCSell

Teladoc Health, Inc.

CEO

$6.7M−4.0%Oct 9
TDOCSell

Teladoc Health, Inc.

CEO

$6.7M−4.0%Sep 4
TDOCSell

Teladoc Health, Inc.

CEO

$7.4M−4.0%Aug 7
TDOCSell

Teladoc Health, Inc.

CEO

$6.6M−4.0%Jul 10
TDOCSell

Teladoc Health, Inc.

CEO

$4.2M−4.0%Jun 5
TDOCSell

Teladoc Health, Inc.

CEO

$6.8M−6.0%May 11
TDOCSell

Teladoc Health, Inc.

CEO

$1.2M−3.0%May 20
TDOCSell

Teladoc Health, Inc.

CEO

$1.6M−4.0%Apr 18
TDOCSell

Teladoc Health, Inc.

CEO

$1.9M−5.0%Mar 21
TDOCSell

Teladoc Health, Inc.

CEO

$2.1M−5.0%Feb 21
TDOCSell

Teladoc Health, Inc.

CEO

$1.9M−5.0%Jan 23
TDOCSell

Teladoc Health, Inc.

CEO

$1.5M−5.0%Dec 21
TDOCSell

Teladoc Health, Inc.

CEO

$1.9M−6.0%Nov 21
TDOCSell

Teladoc Health, Inc.

CEO

$1.8M−5.0%Oct 19
TDOCSell

Teladoc Health, Inc.

CEO

$1.9M−4.0%Sep 18
TDOCSell

Teladoc Health, Inc.

CEO

$1.8M−4.0%Aug 17
TDOCSell

Teladoc, Inc.

CEO

$1.7M−4.0%Jul 18
TDOCSell

Teladoc, Inc.

CEO

$1.5M−4.0%Jun 19
TDOCSell

Teladoc, Inc.

CEO

$1.2M−4.0%May 17
TDOCSell

Teladoc, Inc.

CEO

$1.0M−4.0%Apr 18
TDOCSell

Teladoc, Inc.

CEO

$1.7M−6.0%Mar 14
TDOCSell

Teladoc, Inc.

CEO

$3.3M−12.0%Dec 4
TDOCSell

Teladoc, Inc.

CEO

$642K−2.0%Nov 6
TDOCSell

Teladoc, Inc.

President and CEO

$669K−2.0%Oct 4
TDOCSell

Teladoc, Inc.

President and CEO

$657K−2.0%Jun 7
About Jason N Gorevic

Jason N. Gorevic is a corporate executive and board director who serves as a Director on the Board of Kemper Corporation (NYSE: KMPR).( He joined Kemper’s Board effective February 2, 2022, bringing more than 25 years of healthcare-industry leadership, with executive experience in risk management, strategic planning, and corporate transactions that the company cites as particularly valuable for its technology-focused, consumer-facing businesses in regulated markets.( As a Kemper director, he has reported insider ownership of Kemper shares and has participated in equity transactions in the company’s stock, including an acquisition of 3,000 KMPR shares in August 2022.(

Gorevic is best known as the former Chief Executive Officer of Teladoc Health, Inc., where he led the virtual-care company for about 15 years and helped transform it into a global leader in whole-person virtual medical care.( Under his leadership, Teladoc Health achieved substantial growth in revenue, membership, and care visits and completed major strategic transactions, including large-scale acquisitions in digital health.( Earlier in his career, he held senior roles at WellPoint, Inc. (now Anthem/Elevance Health), including Chief Marketing & Product Officer and President of Empire BlueCross BlueShield.( He began his healthcare career at Oxford Health and has been recognized among the most influential people in healthcare by Modern Healthcare.( Gorevic holds a Bachelor of Arts in International Relations from the University of Pennsylvania.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.